SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-192169
Filing Date
2024-08-02
Accepted
2024-08-02 08:19:52
Documents
15
Period of Report
2024-08-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d866644d8k.htm   iXBRL 8-K 24758
2 EX-99.1 d866644dex991.htm EX-99.1 9410
6 GRAPHIC g866644g0802072724077.jpg GRAPHIC 1883
  Complete submission text file 0001193125-24-192169.txt   159950

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA me-20240802.xsd EX-101.SCH 2831
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20240802_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20240802_pre.xml EX-101.PRE 10801
18 EXTRACTED XBRL INSTANCE DOCUMENT d866644d8k_htm.xml XML 3561
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 241168946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)